Screener
BioMarin Pharmaceuticals BMRN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's current ratio?
- BioMarin Pharmaceuticals (BMRN) reported current ratio of 2.4× in Q2 2026.
- How has BioMarin Pharmaceuticals's current ratio changed year-over-year?
- BioMarin Pharmaceuticals's current ratio decreased by 57.1% year-over-year, from 5.6× to 2.4×.
- What is the long-term trend for BioMarin Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's current ratio has grown at a 1.8% compound annual growth rate (CAGR), from 4.8× to 5.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about BioMarin Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude